Erik Kinnman
Chief Executive Officer at VIVESTO AB
Network origin in Erik Kinnman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
19
| Public Company | Pharmaceuticals: Major | 19 |
| Public Company | Pharmaceuticals: Major | 17 | |
| Public Company | Pharmaceuticals: Major | 11 | |
| Public Company | Pharmaceuticals: Generic | 8 | |
| Private Company | Pharmaceuticals: Major | 7 | |
| Public Company | Pharmaceuticals: Major | 3 | |
Stayble AB
1
| Private Company | 1 | |
| Public Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Erik Kinnman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Uppsala | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree Graduate Degree | |
| Stockholm School of Economics | College/University | Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| Karolinska Institutet | College/University | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Chairman Director/Board Member Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| University of Gothenburg | College/University | Masters Business Admin Graduate Degree Corporate Officer/Principal Graduate Degree | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| Chalmers University of Technology | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Director/Board Member Comptroller/Controller/Auditor | |
| OREXO AB | Pharmaceuticals: Major | Chairman Chairman Chief Tech/Sci/R&D Officer | |
| AEROCRINE AB | Electronic Equipment/Instruments | Director/Board Member Founder | |
Maas Biolab LLC
 Maas Biolab LLC Pharmaceuticals: MajorHealth Technology Maas Biolab LLC manufactures vaccines for chronic neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's, and Alzheimer's. The American company was founded by Marcus Keep and Eskil Elmér, with Marcus Keep serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Investor Relations Contact Director/Board Member | |
| Sahlgrenska University | College/University | Director/Board Member Corporate Officer/Principal | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Investor Relations Contact Director/Board Member | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chairman Director/Board Member | |
SAGA Diagnostics AB
 SAGA Diagnostics AB Medical/Nursing ServicesHealth Services Saga Diagnostics AB operates as a personalized cancer medicine and disease monitoring company. The firm's services include Gene Mutation analysis, circulating tumor DNA and Chromosome analysis. The company was founded by Lao Saal and Anthony George in 2016 and is headquartered in Lund, Sweden. | Medical/Nursing Services | Chairman Corporate Officer/Principal | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| HOIST FINANCE AB | Miscellaneous Commercial Services | Director/Board Member Comptroller/Controller/Auditor | |
| ACUCORT AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Immodulate Pharma AB | Director/Board Member Director/Board Member | ||
| Handelshögskolan i Göteborg | College/University | Undergraduate Degree Graduate Degree | |
CarryGenes Therapeutics AB
 CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| LIDDS AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ISOFOL MEDICAL AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| BONESUPPORT HOLDING AB | Medical Specialties | Chairman Director/Board Member | |
| TOLERANZIA AB | Biotechnology | Chairman Director of Finance/CFO | |
| University of Copenhagen | College/University | Director/Board Member Doctorate Degree | |
| COMBIGENE AB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
OBN (UK) Ltd.
 OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Chairman Chairman | |
Hi3G Access AB
 Hi3G Access AB Specialty TelecommunicationsCommunications Hi3G Access AB provides mobile communication services. It offers cellular phone services, paging services, wireless Internet access, and wireless video services. The company was founded in December 2000 and is headquartered in Stockholm, Sweden. | Specialty Telecommunications | Director/Board Member Director/Board Member | |
| XINTELA AB | Biotechnology | Director/Board Member Chairman | |
Panion Animal Health AB
 Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Agricultural Commodities/Milling | Chairman Director/Board Member | |
Hi3G Denmark ApS
 Hi3G Denmark ApS Specialty TelecommunicationsCommunications Hi3G Denmark ApS provides wireless communication services. It also provides video communication, downloadable music and news. The company was founded in 2001 and is headquartered in Copenhagen, Denmark. | Specialty Telecommunications | Director/Board Member Director/Board Member | |
| XBRANE BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Statistics
International
| Sweden | 45 |
| Denmark | 4 |
| United States | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Finance | 4 |
| Communications | 3 |
Operational
| Director/Board Member | 415 |
| Chairman | 153 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 82 |
| Chief Executive Officer | 80 |
Most connected contacts
- Stock Market
- Insiders
- Erik Kinnman
- Company connections
